Risperidone for Schizoaffective Disorder: Efficacy and Safety

Safety and Tolerability Profile

Risperidone appears most likely to produce extrapyramidal symptoms among atypical antipsychotics, though still less than traditional neuroleptics, according to the American Academy of Child and Adolescent Psychiatry 1, 2
The American Academy of Child and Adolescent Psychiatry recommends checking baseline liver function tests with periodic monitoring during ongoing therapy, as risperidone has been associated with transient hepatic transaminase elevations and rare cases of liver enzyme abnormalities with fatty infiltrates in adolescents 2
Monitoring for weight gain is necessary, as it is the most common significant problem with atypical antipsychotics including risperidone, as stated by the American Academy of Child and Adolescent Psychiatry 1
Documenting any preexisting abnormal movements before initiating treatment is crucial to avoid later mislabeling them as medication side effects, according to the American Academy of Child and Adolescent Psychiatry 3
The American Academy of Child and Adolescent Psychiatry advises being aware of the potential for orthostatic hypotension, QT prolongation, and rare hematological effects including leukocytopenia 2

In children and adolescents with psychotic disorders, the American Academy of Child and Adolescent Psychiatry recommends newer atypical antipsychotics like risperidone over first-generation antipsychotics due to possible increased sensitivity to extrapyramidal symptoms 4, 5, 6
The American Academy of Child and Adolescent Psychiatry suggests that the treatment approach for youth with schizoaffective disorder should be similar to that for children without intellectual disability, using atypical antipsychotics as first-line agents 5